Doxapram hydrochloride (BioDeep_00000705724)
代谢物信息卡片
2-Pyrrolidinone,1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, hydrochloride (1:1)
化学式: C24H31ClN2O2 (414.2073936)
中文名称: 盐酸多沙普仑
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4.Cl
InChI: 1H
描述信息
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants
D019141 - Respiratory System Agents
同义名列表
数据库引用编号
6 个数据库交叉引用编号
- ChEBI: CHEBI:59837
- ChEBI: CHEBI:31520
- PubChem: 64647
- ChEMBL: CHEMBL1200876
- MeSH: Doxapram
- CAS: 113-07-5
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Soroush Sabiza, Hadi Naddaf, Seyedeh Misagh Jalali, Ali Baniadam, Bahman Mosallanejad. The effects of doxapram on haematology, serum biochemical parameters and erythrocyte oxidant/ antioxidant status in dogs anaesthetized with propofol.
Veterinary medicine and science.
2021 03; 7(2):586-592. doi:
10.1002/vms3.398. [PMID: 33210449] - Aline G J Engbers, Swantje Völler, Christian F Poets, Catherijne A J Knibbe, Irwin K M Reiss, Birgit C P Koch, Robert B Flint, Sinno H P Simons. The Pharmacokinetics of Caffeine in Preterm Newborns: No Influence of Doxapram but Important Maturation with Age.
Neonatology.
2021; 118(1):106-113. doi:
10.1159/000513413. [PMID: 33626528] - Robert B Flint, Soma Bahmany, Bart C H van der Nagel, Birgit C P Koch. Simultaneous quantification of fentanyl, sufentanil, cefazolin, doxapram and keto-doxapram in plasma using liquid chromatography-tandem mass spectrometry.
Biomedical chromatography : BMC.
2018 Oct; 32(10):e4290. doi:
10.1002/bmc.4290. [PMID: 29768657] - Tomoyuki Shimokaze, Katsuaki Toyoshima, Jun Shibasaki, Yasufumi Itani. Blood potassium and urine aldosterone after doxapram therapy for preterm infants.
Journal of perinatology : official journal of the California Perinatal Association.
2018 06; 38(6):702-707. doi:
10.1038/s41372-018-0087-x. [PMID: 29515224] - M Roozekrans, E Olofsen, R van der Schrier, M Boom, R Mooren, A Dahan. Doxapram-mediated Increase in Cardiac Output Reduces Opioid Plasma Concentrations: A Pharmacokinetic/Pharmacodynamic-Pharmacokinetic/Pharmacodynamic Modeling Study in Healthy Volunteers.
Clinical pharmacology and therapeutics.
2017 07; 102(1):115-122. doi:
10.1002/cpt.601. [PMID: 28001306] - Yuki Suzuki, Noboru Kamada, Hitoshi Ohno, Yoshikazu Abe, Takuro Endo, Mamoru Kobayashi. Development and validation of an LC-MS/MS method for simultaneously determining doxapram and keto-doxapram in human serum.
Bioanalysis.
2017 Mar; 9(6):503-515. doi:
10.4155/bio-2016-0267. [PMID: 28225296] - Robert B Flint, Willem van Weteringen, Swantje Voller, Jarinda A Poppe, Birgit C P Koch, Ronald de Groot, Dick Tibboel, Catherijne A J Knibbe, Irwin K M Reiss, Sinno H P Simons, Dino Research Group. Big Data Analyses for Continuous Evaluation of Pharmacotherapy: A Proof of Principle with Doxapram in Preterm Infants.
Current pharmaceutical design.
2017; 23(38):5919-5927. doi:
10.2174/1381612823666170918121556. [PMID: 28925893] - E Greze, M Benard, I Hamon, C Casper, F E Haddad, M-J Boutroy, J-M Hascoët. Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial.
Paediatric drugs.
2016 Dec; 18(6):443-449. doi:
10.1007/s40272-016-0192-2. [PMID: 27612991] - Yuki Ogawa, Mitsuru Irikura, Yuka Kobaru, Mayu Tomiyasu, Yoshie Kochiyama, Mamiko Uriu, Yoichi Ishitsuka, Yuki Kondo, Eiji Yukawa, Noboru Kamada, Hitoshi Ohno, Toshio Yamazaki, Tetsumi Irie. Population pharmacokinetics of doxapram in low-birth-weight Japanese infants with apnea.
European journal of pediatrics.
2015 Apr; 174(4):509-18. doi:
10.1007/s00431-014-2416-1. [PMID: 25248340] - Céline Fischer, Cyril Ferdynus, Jean-Bernard Gouyon, Denis S Semama. Doxapram and hypokalaemia in very preterm infants.
Archives of disease in childhood. Fetal and neonatal edition.
2013 Sep; 98(5):F416-8. doi:
10.1136/archdischild-2012-303089. [PMID: 23448699] - Ryu Komatsu, Papiya Sengupta, Grigory Cherynak, Anupama Wadhwa, Daniel I Sessler, Jin Liu, Harrell E Hurst, Rainer Lenhardt. Doxapram only slightly reduces the shivering threshold in healthy volunteers.
Anesthesia and analgesia.
2005 Nov; 101(5):1368-1373. doi:
10.1213/01.ane.0000180198.13467.df. [PMID: 16243996] - M Bénard, M J Boutroy, I Glorieux, C Casper. [Determinants of doxapram utilization: a survey of practice in the French Neonatal and Intensive Care Units].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
2005 Feb; 12(2):151-5. doi:
10.1016/j.arcped.2004.10.024. [PMID: 15694538] - C Maillard, M J Boutroy, J Fresson, F Barbé, J M Hascoët. QT interval lengthening in premature infants treated with doxapram.
Clinical pharmacology and therapeutics.
2001 Dec; 70(6):540-5. doi:
10.1067/mcp.2001.120761. [PMID: 11753270] - J Bhatia. Current options in the management of apnea of prematurity.
Clinical pediatrics.
2000 Jun; 39(6):327-36. doi:
10.1177/000992280003900602. [PMID: 10879934] - S Kanno, M Ishikawa, M Takayanagi, Y Takayanagi, K Sasaki. Combination acetaminophen and doxapram potentiated hepatotoxicity in mouse primary cultured hepatocytes.
Methods and findings in experimental and clinical pharmacology.
1999 Dec; 21(10):647-52. doi:
10.1358/mf.1999.21.10.795700. [PMID: 10702959] - F Barbé, C Hansen, Y Badonnel, H Legagneur, P Vert, M J Boutroy. Severe side effects and drug plasma concentrations in preterm infants treated with doxapram.
Therapeutic drug monitoring.
1999 Oct; 21(5):547-52. doi:
10.1097/00007691-199910000-00011. [PMID: 10519454] - C F Poets, S Darraj, B Bohnhorst. Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants.
Biology of the neonate.
1999 Oct; 76(4):207-13. doi:
10.1159/000014160. [PMID: 10473894] - J C Möller, A Austing, B Püst, M Kohl, I Reiss, H Iven, L Gortner. [A comparative study about the therapeutic effect of theophylline and doxapram in apnoeic disorders].
Klinische Padiatrie.
1999 Mar; 211(2):86-91. doi:
10.1055/s-2008-1043772. [PMID: 10407818] - C Huon, E Rey, P Mussat, S Parat, G Moriette. Low-dose doxapram for treatment of apnoea following early weaning in very low birthweight infants: a randomized, double-blind study.
Acta paediatrica (Oslo, Norway : 1992).
1998 Nov; 87(11):1180-4. doi:
10.1080/080352598750031185. [PMID: 9846921] - S Kanno, M Ishikawa, M Takayanagi, Y Takayanagi, K Sasaki. Potentiation of acetaminophen hepatotoxicity and mortality by doxapram in mice.
Biological & pharmaceutical bulletin.
1998 Sep; 21(9):934-7. doi:
10.1248/bpb.21.934. [PMID: 9781842] - L Björk, M Arborelius, H Renck, B Rosberg. Metabolic, ventilatory and circulatory effects of doxapram in anaesthetized pigs during normoxia and hypoxia.
Acta anaesthesiologica Scandinavica.
1996 Sep; 40(8 Pt 1):919-26. doi:
10.1111/j.1399-6576.1996.tb04561.x. [PMID: 8908229] - J L Abelson, J G Weg, R M Nesse, G C Curtis. Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model.
Psychoneuroendocrinology.
1996 May; 21(4):375-90. doi:
10.1016/0306-4530(96)00005-4. [PMID: 8844876] - R A Sams, R L Detra, W W Muir. Pharmacokinetics and metabolism of intravenous doxapram in horses.
Equine veterinary journal. Supplement.
1992 Feb; ?(11):45-51. doi:
10.1111/j.2042-3306.1992.tb04772.x. [PMID: 9109960] - A Bairam, P W Blanchard, M A Bureau, N Laudignon, A Cote, J V Aranda. Interactive ventilatory effects of two respiratory stimulants, caffeine and doxapram, in newborn lambs.
Biology of the neonate.
1992; 61(3):201-8. doi:
10.1159/000243743. [PMID: 1610947] - A Bairam, E Canet, J P Praud, J V Aranda, M A Bureau. Ventilatory response to keto-doxapram in intact and carotid body denervated lambs.
Respiration physiology.
1991 Dec; 86(3):345-54. doi:
10.1016/0034-5687(91)90105-r. [PMID: 1788494] - M Ishikawa, I Suzuki, M Ozaki, Y Takayanagi, K Sasaki. Interaction of doxapram and pentobarbital in mice.
Pharmacology & toxicology.
1991 Oct; 69(4):276-81. doi:
10.1111/bcpt.1991.69.4.276. [PMID: 1956880] - R T Coutts, F Jamali, F Malek, A Peliowski, N N Finer. Urinary metabolites of doxapram in premature neonates.
Xenobiotica; the fate of foreign compounds in biological systems.
1991 Oct; 21(10):1407-18. doi:
10.3109/00498259109043215. [PMID: 1796617] - H Kumita, S Mizuno, M Shinohara, T Ichikawa, T Yamazaki. Low-dose doxapram therapy in premature infants and its CSF and serum concentrations.
Acta paediatrica Scandinavica.
1991 Aug; 80(8-9):786-91. doi:
10.1111/j.1651-2227.1991.tb11949.x. [PMID: 1957596] - A Bairam, L Akramoff-Gershan, K Beharry, N Laudignon, A Papageorgiou, J V Aranda. Gastrointestinal absorption of doxapram in neonates.
American journal of perinatology.
1991 Mar; 8(2):110-3. doi:
10.1055/s-2007-999357. [PMID: 2006935] - F Jamali, R T Coutts, F Malek, N N Finer, A Peliowski. Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity.
Developmental pharmacology and therapeutics.
1991; 16(2):78-82. doi:
10.1159/000480562. [PMID: 1914782] - B J Pollard, N P Randall, B J Pleuvry. Doxapram and the neuromuscular junction.
British journal of anaesthesia.
1989 Jun; 62(6):664-8. doi:
10.1093/bja/62.6.664. [PMID: 2751921] - N P Randall, B J Pleuvry, E J Fazackerley, C Y Modla, L F Prescott, T E Healy. Effect of oral doxapram on morphine-induced changes in the ventilatory response to carbon dioxide.
British journal of anaesthesia.
1989 Feb; 62(2):159-63. doi:
10.1093/bja/62.2.159. [PMID: 2493800] - F Jamali, K J Barrington, N N Finer, R T Coutts, G A Torok-Both. Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data.
Developmental pharmacology and therapeutics.
1988; 11(5):253-7. doi:
10.1159/000457699. [PMID: 3191816] - M A Beaudry, J M Bradley, L M Gramlich, D LeGatt. Pharmacokinetics of doxapram in idiopathic apnea of prematurity.
Developmental pharmacology and therapeutics.
1988; 11(2):65-72. doi:
10.1159/000457668. [PMID: 3371147] - S Okubo, K Konno, T Ishizaki, T Suganuma, T Takubo, T Takizawa, M Tanaka. Serum doxapram and respiratory neuromuscular drive in normal man.
European journal of clinical pharmacology.
1988; 34(1):55-9. doi:
10.1007/bf01061418. [PMID: 3360049] - K J Barrington, N N Finer, G Torok-Both, F Jamali, R T Coutts. Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity.
Pediatrics.
1987 Jul; 80(1):22-7. doi:
NULL. [PMID: 3110729] - F Hayakawa, S Hakamada, K Kuno, T Nakashima, Y Miyachi. Doxapram in the treatment of idiopathic apnea of prematurity: desirable dosage and serum concentrations.
The Journal of pediatrics.
1986 Jul; 109(1):138-40. doi:
10.1016/s0022-3476(86)80594-7. [PMID: 3723234] - D F LeGatt, M A Beaudry, J M Bradley. Simultaneous determination of doxapram and 2-ketodoxapram in plasma of neonates by gas chromatography.
Journal of chromatography.
1986 Jun; 378(2):478-81. doi:
10.1016/s0378-4347(00)80746-x. [PMID: 3734004] - G A Torok-Both, R T Coutts, F Jamali, F M Pasutto, K J Barrington. Sensitive nitrogen-phosphorus capillary gas chromatographic assay for doxapram in premature infants.
Journal of chromatography.
1985 Nov; 344(?):372-7. doi:
10.1016/s0378-4347(00)82043-5. [PMID: 4086561] - K Johnston, C J Newth, K F Sheu, M S Patel, G P Heldt, K A Schmidt, S Packman. Central hypoventilation syndrome in pyruvate dehydrogenase complex deficiency.
Pediatrics.
1984 Dec; 74(6):1034-40. doi:
NULL. [PMID: 6438601] - P M Calverley, R H Robson, P K Wraith, L F Prescott, D C Flenley. The ventilatory effects of doxapram in normal man.
Clinical science (London, England : 1979).
1983 Jul; 65(1):65-9. doi:
10.1042/cs0650065. [PMID: 6406129] - K Sasaki, S Furusawa, G Takayanagi. Formation of lipid peroxide in doxapram-treated mice.
Chemical & pharmaceutical bulletin.
1982 Nov; 30(11):4159-63. doi:
10.1248/cpb.30.4159. [PMID: 7165880] - K Sasaki, S Furusawa, G Takayanagi. Effect of doxapram on the action of other drugs and the hepatic drug-metabolizing system in mice.
Japanese journal of pharmacology.
1982 Aug; 32(4):699-707. doi:
10.1254/jjp.32.699. [PMID: 7131953] - K Sasaki, S Furusawa, G Takayanagi. Biphasic effect of doxapram on hypnotic activity of pentobarbital in mice.
Journal of pharmacobio-dynamics.
1981 Jun; 4(6):394-401. doi:
10.1248/bpb1978.4.394. [PMID: 7288556] - J R Baker, C C Peck, B D Raybuck, E L Owens, B G Schuster. Normal pharmacokinetics of doxapramin in a patient with renal failure and hypothyroidism.
British journal of clinical pharmacology.
1981 Mar; 11(3):305-7. doi:
10.1111/j.1365-2125.1981.tb00539.x. [PMID: 7213532] - H Nichol, J Vine, J Thomas, R G Moore. Quantitation of doxapram in blood, plasma and urine.
Journal of chromatography.
1980 May; 182(2):191-200. doi:
10.1016/s0378-4347(00)81623-0. [PMID: 7380911] - J A Clements, R H Robson, L F Prescott. Plasma concentrations of doxapram in man during variable-rate intravenous infusion [proceedings].
The Journal of pharmacy and pharmacology.
1979 Dec; 31 Suppl(?):41P. doi:
10.1111/j.2042-7158.1979.tb11589.x. [PMID: 42716] - R H Robson, L F Prescott. A pharmacokinetic study of doxapram in patients and volunteers.
British journal of clinical pharmacology.
1979 Jan; 7(1):81-7. doi:
10.1111/j.1365-2125.1979.tb00901.x. [PMID: 32901] - J A Clements, R H Robson, L F Prescott. The disposition of intravenous doxapram in man.
European journal of clinical pharmacology.
1979; 16(6):411-6. doi:
10.1007/bf00568202. [PMID: 527638] - B A Flint, I K Ho, B P Mo, B M Rigor. Enhancement of pharmacologic responses of pentobarbital by dopram.
Clinical toxicology.
1979; 15(2):169-79. doi:
10.3109/15563657908989862. [PMID: 509882] - R H Robson, L F Prescott. Rapid gas--liquid chromatographic estimation of doxapram in plasma.
Journal of chromatography.
1977 Sep; 143(5):527-9. doi:
10.1016/s0378-4347(00)81800-9. [PMID: 893642] - W N Piercy, M A Day, A H Neims, R L Williams. Alteration of ovine fetal respiratory-like activity by diazepam, caffeine, and doxapram.
American journal of obstetrics and gynecology.
1977 Jan; 127(1):43-9. doi:
10.1016/0002-9378(77)90312-x. [PMID: 831485] - C J Jones, D K Luscombe, P J Nicholls. Proceedings: Absorption, distribution and excretion of doxapram hydrochloride in the rat.
The Journal of pharmacy and pharmacology.
1973 Dec; 25(?):Suppl:139P-140. doi:
NULL. [PMID: 4150542] - J E Pitts, R B Bruce, J B Forehand. Identification of doxapram metabolites using high pressure ion exchange chromatography and mass spectroscopy.
Xenobiotica; the fate of foreign compounds in biological systems.
1973 Feb; 3(2):73-83. doi:
10.3109/00498257309151502. [PMID: 4716642] - G W Branham, W R Wooles. Hepatic lipid alterations produced by doxapram.
Toxicology and applied pharmacology.
1966 Sep; 9(2):347-55. doi:
10.1016/0041-008x(66)90131-1. [PMID: 4381871] - R B BRUCE, J E PITTS, F PINCHBECK, J NEWMAN. EXCRETION, DISTRIBUTION, AND METABOLISM OF DOXAPRAM HYDROCHLORIDE.
Journal of medicinal chemistry.
1965 Mar; 8(?):157-64. doi:
10.1021/jm00326a004. [PMID: 14332655]